Hostname: page-component-7479d7b7d-q6k6v Total loading time: 0 Render date: 2024-07-12T01:29:15.418Z Has data issue: false hasContentIssue false
  • English
  • Français

New developments in pre-eclampsia

Published online by Cambridge University Press:  10 October 2008

James M Roberts ,
Robert N Taylor ,
Steven A Friedman  and
Alan Goldfien
James M Roberts*
Affiliation:
University of California, San Francisco, USA
Robert N Taylor
Affiliation:
University of California, San Francisco, USA
Steven A Friedman
Affiliation:
University of California, San Francisco, USA
Alan Goldfien
Affiliation:
University of California, San Francisco, USA
*
James M Roberts, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, USA.
Get access Rights & Permissions [Opens in a new window]

Extract

It is quite clear that pre-eclampsia is not simply pregnancy-induced hypertension; rather, it is a multisystem disease with pathophysiological changes secondary to reduced organ perfusion. This reduction can be explained by vasospasm secondary to increased sensitivity of the vasculature to usual circulating pressors, and vascular occlusion secondary to activation of the coagulation cascade. Although pre-eclampsia becomes clinically evident late in pregnancy, pathological and pathophysiological changes antedate the clinical syndrome by weeks to months. The syndrome occurs only in pregnancy and is cured by the removal of fetoplacental tissues.

Based on these findings, we have proposed that the inciting pathophysiological change of preeclampsia is reduced trophoblastic perfusion, which produces an agent that perturbs endothelial cells. The altered endothelial functions associated with this insult increase sensitivity to pressors, activate the coagulation cascade and produce the clinical and pathological findings of preeclampsia. Although we feel this hypothesis could explain pre-eclampsia, it is possible that its major value will be to stimulate others to approach this disorder by considering all facets of its pathophysiology rather than merely its hypertensive component.

The appreciation of pre-eclampsia as a disease present from early pregnancy and the potential role of vasodilator prostaglandins have already stimulated therapeutic trials of aspirin in women at very high risk with encouraging results. At present, information is insufficient to determine the risk/benefit ratio of this therapy in lower risk patients, and aspirin therapy should not be used in these women. Another potential modification of therapy, the substitution of phenytoin for magnesium sulphate, does not seem warranted on the basis of either currently available data or on theoretical grounds.

Fruitful directions for research in the near future will be the explanation of the abnormal trophoblastic invasion of pre-eclampsia and the determination of how reduced perfusion translates into a multisystem disease. In addition, aspirin therapy or other potential prophylactic therapies would be greatly aided by the development of new tests with reasonable positive predictive values, in order to identify preeclampsia prior to clinically evident disease.

Type
Articles
Information
Fetal and Maternal Medicine Review , Volume 2 , Issue 2 , July 1990 , pp. 125 - 141
Copyright
Copyright © Cambridge University Press 1990

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Chesley, LC. Hypertensive disorders in pregnancy. New York: Appleton-Century-Crofts, 1978.Google Scholar
Pritchard, JA, Cunningham, FG, Pritchard, SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. Am J Obstet Gynecol 1984; 148: 951–63.CrossRefGoogle ScholarPubMed
Roberts, JM, Taylor, RN, Musci, TJ, Rodgers, GM, Hubel, CA, McLaughlin, MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200–1204.CrossRefGoogle ScholarPubMed
Hubel, CA, Roberts, JM, Taylor, RN, Musci, TJ, Rodgers, GM, McLaughlin, MK. Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am J Obstet Gynecol 1989; 161: 1025–34.CrossRefGoogle ScholarPubMed
Redman, CWG, Beilin, LJ, Bonnar, J, Wilkinson, RH. Plasma-urate measurements in predicting fetal death in hypertensive pregnancy. Lancet 1976; 1: 1370–73.CrossRefGoogle ScholarPubMed
Howie, PW, Beg, CB, Purdie, DW, Prentice, CRM. Use of coagulation tests to predict the clinical progress of pre-eclampsia. Lancet 1976; 2: 323–25.CrossRefGoogle ScholarPubMed
Roberts, JM. Pregnancy related hypertension. In: Creasy, RK, Resnik, R eds, Maternal fetal medicine: principles and practice, Philadelphia: WB Saunders, 1989.Google Scholar
McCartney, CP. Pathological anatomy of acute hypertension of pregnancy. Circulation 1964; 30(suppl 2): 37–42.CrossRefGoogle ScholarPubMed
Ramsey, EM, Harris, HWS. Comparison of uteroplacental vasculature and circulation in the rhesus monkey and man. Contributions to embryology, No. 261, 1966; 38: 59–69.Google Scholar
Robertson, WB, Khong, TY, Brosens, I, Wolf, FD, Sheppard, BL, Bonnar, J. The placental bed biopsy: review from three European centers. Am J Obstet Gynecol 1986; 155: 401–12.CrossRefGoogle ScholarPubMed
Pijnenborg, R, Robertson, WB, Brosens, I, Dixon, G. Trophoblast invasion and the establishment of haemochorial placentation in man and laboratory animals. Placenta 1981; 2: 71–92.CrossRefGoogle ScholarPubMed
Zeek, PM, Assali, NS. Vascular changes in the decidua associated with eclamptogenic toxemia. Am J Clin Pathol 1950; 20: 1099.CrossRefGoogle ScholarPubMed
Kitzmiller, JL, Benirschke, K. Immunofluorescent study of placental bed vessels in pre-eclampsia. Am J Obstet Gynecol 1973; 115: 248–51.Google Scholar
Lichtig, C, Deutsch, M, Brandes, J. Immunofluorescent studies of the endometrial arteries in the first trimester of pregnancy. Am J Clin Pathol 1985; 83: 633–36.CrossRefGoogle ScholarPubMed
Phelan, JP, Yurth, DA. Severe preeclampsia. I. Peripartum hemodynamic observations. Am J Obstet Gynecol 1982; 144: 17–22.CrossRefGoogle ScholarPubMed
Cotton, DB, Lee, W, Huhta, JC, Dorman, KF. Hemodynamic profile of severe pregnancy-induced hypertension. Am J Obstet Gynecol 1988; 158: 523–29.CrossRefGoogle ScholarPubMed
Clark, SL, Greenspoon, JS, Aldahl, D, Phelan, JP. Severe preeclampsia with persistent oliguria: management of hemodynamic subsets. Am J Obstet Gynecol 1986; 154: 490–94.CrossRefGoogle ScholarPubMed
Groenendijk, R, Trimbos, JB, Wallenburg, HC. Hemodynamic measurements in preeclampsia: preliminary observations. Am J Obstet Gynecol 1984; 150: 232–36.CrossRefGoogle ScholarPubMed
Spetz, S. Peripheral circulation in pregnancy complicated by toxaemia. Acta Obstet Gynaecol Scand 1965; 44: 243–57.CrossRefGoogle ScholarPubMed
Gordon, RD, Symonds, EM, Wilmhurst, EG, Pawsey, CGK. Plasma renin activity, plasma angiotensin and plasma and urinary electrolytes in normal and toxaemic pregnancy, including a prospective study. Clin Sci Mol Med 1973; 45: 115–27.Google ScholarPubMed
Poland, ML, Lucas, CP. Plasma epinephrine and norepinephrine in normotensive and pregnancy-induced hypertensive pregnancies. In: Bonnar, J, MacGillivary, I, Symonds, EM eds, Pregnancy hypertension, Baltimore: University Park Press, 1980.Google Scholar
Pirani, BB, MacGillivray, I. The effect of plasma retransfusion on the blood pressure in pregnancy. Am J Obstet Gynecol 1975; 121: 221–26.CrossRefGoogle Scholar
Schwarz, R, Retzke, U. Cardiovascular response to infusion of angiotensin II in pregnant women. Obstet Gynecol 1971; 38: 714–18.Google Scholar
Zuspan, FP, Nelson, GH, Ahlquist, RP. Epinephrine infusions in normal and toxemic pregnancy. I. Nonesterified fatty acids and cardiovascular alterations. Am J Obstet Gynecol 1964; 90: 88–98.CrossRefGoogle ScholarPubMed
Talledo, OE, Chesley, LC, Zuspan, FP. Renin-angiotensin system in normal and toxemic pregnancies. III. Differential sensitivity to angiotensin II and norepinephrine in toxemia of pregnancy. Am J Obstet Gynecol 1968; 100: 218–21.CrossRefGoogle Scholar
Chesley, LC, Valenti, C. The evaluation of tests to differentiate preeclampsia from hypertensive disease. Am J Obstet Gynecol 1958; 75: 1165.Google Scholar
Gallery, EDM, Stokes, GS, Györy, AZ, Rowe, J, Williams, J. Plasma renin activity in normal human pregnancy and in pregnancy-associated hypertension, with reference to cryoactivation. Clin Sci 1980; 59: 49–53.CrossRefGoogle ScholarPubMed
Arias, F, Mancilla-Jiminez, R. Hepatic fibrinogen deposits in preeclampsia. N Engl J Med 1976; 295: 578–82.CrossRefGoogle ScholarPubMed
Vassali, P, Morris, R, McCluskey, RI. The pathogenic role in fibrin deposition in the glomerular lesions of toxemia of pregnancy. J Exp Med 1963; 118: 467–77.Google Scholar
Matter, L, Faulk, WP. Fibrinogen degradation products and factor VIII consumption in normal pregnancy and preeclampsia: role of the placenta. In: Bonnar, J, MacGillivary, I, Symonds, EM eds, Pregnancy hypertension, Baltimore: University Park Press, 1980.Google Scholar
Pritchard, JA, Cunningham, FG, Mason, RA. Coagulation changes in preeclampsia: their frequency and pathogenesis. Am J Obstet Gynecol 1976; 124: 855–64.CrossRefGoogle Scholar
Weiner, CP, Kwaan, HC, Xu, C, Paul, M, Burmeister, L, Hauck, W. Antithrombin III activity in women with hypertension during pregnancy. Obstet Gynecol 1985; 65: 301–306.Google ScholarPubMed
Redman, CWG, Denson, KWE, Beilin, LJ, Bolton, FG. Factor-VIII consumption in pre-eclampsia. Lancet 1977; 2: 1249–52.CrossRefGoogle ScholarPubMed
Stubbs, TM, Lazarchick, J, van Dorsten, P et al. Evidence of accelerated platelet production and consumption in nonthrombocytopenic preeclampsia. Am J Obstet Gynecol 1986; 155: 263–65.Google Scholar
Douglas, JT, Shah, M, Lowe, GDO, Belch, JJF, Forbes, LCD, Prentice, CRM. Plasma fibrinopeptide a and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension. Thromb Haemost 1982; 7: 54–55.Google Scholar
Gant, NF, Daley, GL, Chand, S, Walley, PJ, MacDonald, PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973; 52: 2682–89.Google Scholar
Gallery, EDM, Hunyor, SN, Ross, M, Györy, AZ. Predicting the development of pregnancy-associated hypertension: the place of standardised blood-pressure measurement. Lancet 1977; 1: 1273–76.CrossRefGoogle ScholarPubMed
Gallery, EDM, Saunders, DH, Boyce, ES, Györy, AZ. Relation between plasma volume and uric acid in the development of hypertension in pregnancy. In: Bonnar, J, MacGillivary, I, Symonds, EM eds, Pregnancy hypertension, Baltimore: University Park Press, 1980.Google Scholar
Gallery, EDM, Gyöory, AZ. Glomerular and proximal renal tubular function in pregnancy-associated hypertension: a prospective study. Eur J Gynecol Reprod Biol 1979; 9: 3–12.CrossRefGoogle ScholarPubMed
Easterling, TR, Benedetti, J. Increased cardiac output prior to the development of the disorder, preeclampsia: a hyperdynamic disease model. Am J Obstet Gynecol 1989; 160: 1447–53.CrossRefGoogle Scholar
Hostetter, TH, Rennke, HG, Brenner, BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982; 72: 375–80.CrossRefGoogle ScholarPubMed
Baylis, C. Renal disease in gravid animal models. Am J Kidney Dis 1987; 9: 350–53.CrossRefGoogle ScholarPubMed
Redman, CW, Bonnar, J, Beilin, L. Early platelet consumption in pre-eclampsia. Br Med J 1978; 1: 467–69.CrossRefGoogle ScholarPubMed
Inglis, TCM, Stuart, J, George, AJ, Davies, AJ. Haemostatic and rheological changes in normal pregnancy and preeclampsia. Br J Haematol 1982; 50: 461–65.CrossRefGoogle ScholarPubMed
Friedman, SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol 1988; 71: 122–37.Google ScholarPubMed
Everett, RB, Worley, RJ, McDonald, PC et al. Effect of prostaglandin synthetase inhibitors on pressor response to angiotensin II in human pregnancy. J Clin Endocrinol Metab 1978; 46: 1007–10.Google Scholar
Moncada, S, Vane, JR. Prostacyclin and the vascular endothelium. Bull Eur Physiopathol Resp 1981; 17: 687–701.Google ScholarPubMed
Bussolino, F, Benedetto, C, Massobrio, M, Camussi, G. Maternal vascular prostacyclin activity in pre-eclampsia (letter). Lancet 1980; 2: 702.CrossRefGoogle Scholar
Dadak, C, Kefalides, A, Sinzinger, H, Weber, G. Reduced umbilical artery prostacyclin formation in complicated pregnancies. Am J Obstet Gynecol 1982; 144: 792–95.CrossRefGoogle ScholarPubMed
Yamaguchi, M, Mori, N. 6-keto prostaglandin Flα, thromboxane B2, and 13,14-dihydro-15-keto prostaglandin F concentrations of normotensive and preeclamptic patients during pregnancy, delivery, and the postpartum period. Am J Obstet Gynecol 1985; 151: 121–27.CrossRefGoogle Scholar
Koullapis, EN, Nicolaides, KH, Collins, WP et al. Plasma prostanoids in pregnancy-induced hypertension. Br J Obstet Gynaecol 1982; 89: 617–21.Google Scholar
Walsh, SW. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985; 152: 335–40.CrossRefGoogle ScholarPubMed
Jaffe, EA. Cell biology of endothelial cells. Hum Pathol 1987; 18: 234–39.Google Scholar
Rodgers, GM. Hemostatic properties of normal and perturbed vascular cells. FASEB J 1988; 2: 116–23.Google Scholar
Vanhoutte, PM, Rubanyi, GM, Miller, VM, Houston, DS. Modulation of vascular smooth muscle contraction by the endothelium. Annu Rev Physiol 1986; 48: 307–20.CrossRefGoogle ScholarPubMed
Harlan, JM, Thompson, PJ, Ross, RR et al. Alpha-thrombin induces release of platelet-derived growth factor-like molecule(s) by cultured human endothelial cells. J Cell Biol 1986; 103: 1129–33.CrossRefGoogle ScholarPubMed
Berk, BC, Alexander, RW, Brock, TA et al. Vasoconstriction: a new activity for platelet-derived growth factor. Science 1986; 232: 87–90.Google Scholar
Yanagisawa, M, Kurihara, H, Kimura, S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–15.CrossRefGoogle ScholarPubMed
Shanklin, DR, Sibai, BM. Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels. Am J Obstet Gynecol 1989; 161: 735–41.CrossRefGoogle ScholarPubMed
Dadak, C, Ulrich, W, Sinzinger, H. Morphological changes in the umbilical arteries of babies born to pre-eclamptic mothers: an ultrastructural study. Placenta 1984; 5: 419–26.CrossRefGoogle ScholarPubMed
Campbell, DM, Campbell, AJ. Evans blue disappearance rate in normal and preeclamptic pregnancy. Clin Exp Hypertens -Hypertension in Pregnancy 1983; 2: 163–69.CrossRefGoogle Scholar
Fournie, A, Monrozies, M, Pontonnier, G, Boneu, B, Bierme, R. Factor VIII complex in normal pregnancy pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol 1981; 88: 250–54.Google Scholar
Lazarchick, J, Stubbs, TM, Romein, L, Van Dorsten, JP, Loadholt, CB. Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic. Am J Obstet Gynecol 1986; 154: 1050–52.CrossRefGoogle ScholarPubMed
Musci, JM, Roberts, JM, Rodgers, GM, Taylor, RN. Mitogenic activity is present in the blood of preeclamptic women. Am J Obstet Gynecol 1988; 159: 1446–51.CrossRefGoogle Scholar
Levin, M, Walters, MDS, Waterfield, MD, Stroobant, P, Cheng, DJ, Barratt, TM. Platelet-derived growth factors as possible mediators of vascular proliferation in the sporadic haemolytic uraemic syndrome. Lancet 1986; 2: 830–33.CrossRefGoogle ScholarPubMed
Tulenko, T, Schneider, J, Floro, C, Sicilla, M. The in vitro effect on arterial wall function of serum from patients with pregnancy-induced hypertension. Am J Obstet Gynecol 1987; 157: 817–23.CrossRefGoogle Scholar
Rodgers, GM, Taylor, RN, Roberts, JM. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol 1988; 159: 908–14.CrossRefGoogle ScholarPubMed
Anderson, KJ, Duncan, SLB, Lunt, RL. Advanced abdominal pregnancy with severe pre-eclampsia. Br J Obstet Gynaecol 1976; 83: 90–93.CrossRefGoogle Scholar
Page, EW. The relation between hydatid moles, relative ischemia of the gravid uterus, and placental origin of eclampsia. Am J Obstet Gynecol 1939; 37: 291.Google Scholar
Bulfin, MJ, Lawler, PE. Problems associated with toxemia in twin pregnancies. Am J Obstet Gynecol 1957; 73: 37–42.Google Scholar
Scott, JS. Pregnancy toxaemia associated with hydrops foetalis, hydatidiform mole and hydramnios. J Obstet Gynaecol Br Emp 1958; 65: 689.CrossRefGoogle ScholarPubMed
Roberts, JM, Perloff, DL. Hypertension and the obstetrician-gynecologist. Am J Obstet Gynecol 1977; 127: 316–23.CrossRefGoogle ScholarPubMed
Hodgkinson, CP, Hodare, AA, Bumpus, FM. Experimental hypertensive disease in pregnancy. Obstet Gynecol 1967; 30: 371–80.Google Scholar
Abitbol, MM. Hemodynamic studies in experimental toxemia of the dog. Obstet Gynecol 1977; 50: 293–98.Google Scholar
Berger, M, Cavanagh, D. Toxemia of pregnancy: the hypertensive effect of acute experimental placental ischemia. Am J Obstet Gynecol 1963; 87: 293–305.Google Scholar
Rappaport, V, Hirata, G, Yap, HK, Jordan, S. Anti-endothelial cell antibodies in severe preeclampsia. Presented at the 35th meeting of the Society for Gynecological Investigation, 1988.Google Scholar
Pober, JS. Cytokine-mediated activation of vascular endothelium. Physiology and pathology. Am J Pathol 1988; 133: 426–33.Google ScholarPubMed
Hubel, CA, Roberts, JM, Taylor, RN, Musci, TJ, Rogers, GM, McLaughlin, MK. Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am J Obstet Gynecol 1989; 161: 1025–34.CrossRefGoogle ScholarPubMed
Ishihara, M. Studies on lipoperoxide of normal pregnant women and of patients with toxemia of pregnancy. Clin Chim Acta 1978; 84: 1–9.Google Scholar
Moncada, S, Vane, JR.Pharmacology and endogenous roles of prostacyclin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev 1979; 30: 293–331.Google Scholar
Beaufils, M, Uzan, S, Donsimoni, R, Colau, JC. Prospective controlled study of early antiplatelet therapy in prevention of preeclampsia. Adv Nephrol 1986; 15: 87–94.Google Scholar
Wallenburg, HC, Dekker, GA, Makovitz, JW, Rotmans, P. Low-dose aspirin prevents pregnancy-induced hypertension and preeclampsia in angiotensin-sensitive primigravidae. Lancet 1986; 1: 1–3.Google Scholar
Benigni, A, Gregorini, G, Frusca, T et al. Blood supply to the uterus in preeclampsia. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989; 321: 357–62.Google Scholar
Schiff, E, Peleg, E, Goldenberg, M et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2, to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989; 321: 351–56.Google Scholar
Goldenberg, RL, Davis, RO, Baker, RC. Indomethacin-induced oligohydramnios. Am J Obstet Gynecol 1989; 160: 1196–97.Google Scholar
Moise, KJ et al. Indomethacin treatment of preterm labor: effects on the fetal ductus arteriosus. N Engl J Med 1988; 319: 327–31.CrossRefGoogle ScholarPubMed
Manchester, D, Margolis, A, Sheldon, R. Possible association between maternal indomethacin therapy and primary pulmonary hypertension of the newborn. Am J Obstet Gynecol 1976; 126: 467–69.CrossRefGoogle ScholarPubMed
Kaplan, PW, Lesser, RP, Fisher, RS, Repke, JT, Hanley, DF. No, magnesium sulfate should not be used in treating eclamptic seizures. Arch Neurol 1988; ∈45: 1361–64.CrossRefGoogle Scholar
Ryan, G, Lange, IR, Naugler, MA. Clinical experience with phenytoin prophylaxis in severe preeclampsia. Am J Obstet Gynecol 1989; 161: 1297–1304.CrossRefGoogle ScholarPubMed
Slater, RM, Smith, WD, Patrick, J et al. Phenytoin infusion in severe pre-eclampsia. Lancet 1987; 1: 1417–20.CrossRefGoogle ScholarPubMed
Hilmy, MI, Somjen, GG. Distribution and tissue uptake of magnesium related to its pharmacological effects. Am J Obstet Gynecol 1968; 214: 406–13.Google Scholar
Sibai, BM, Spinnato, JA, Watson, DL et al. Effect of magnesium sulfate on electroencephalographic findings in preeclampsia-eclampsia. Obstet Gynecol 1984; 64: 261–66.Google Scholar
Borges, LF, Gucer, G. Effect of magnesium on epileptic foci. Epilepsia 1978; 19: 81–91.CrossRefGoogle ScholarPubMed
Sibai, BM, Lipshitz, J, Anderson, GD, Dilts, PV Jr. Reassessment of intravenous MgSO4 therapy in preeclampsia-eclampsia. Obstet Gynecol 1981; 51: 199–202.Google Scholar
Tuffnell, D, O'Donovan, P, Lilford, RJ, Prys-Davies, A, Thornton, JG. Phenytoin in pre-eclampsia. Lancet 1989; 1: 273–74.CrossRefGoogle Scholar
Winter, ME, Tozer, TN. Phenytoin. In: Evans, WE, Schentag, JJ, Jusko, WJ eds, Applied pharmacokinetics - principles of therapeutic drug monitoring, second edition, San Francisco: Applied Therapeutics, 1986: 493–539.Google Scholar
Watson, KV, Moldow, CF, Ogburn, PL, Jacob, HS. Magnesium sulfate: rationale for its use in preeclampsia. Proc Natl Acad Sci USA 1986; 83: 1075–78.CrossRefGoogle ScholarPubMed
Beck, RW, Menezes, AH. Intracerebral hemorrhage in a patient with eclampsia. JAMA 1981; 246: 1442–43.CrossRefGoogle Scholar
Will, AD, Lewis, KL, Hinshaw, DB et al. Cerebral vasoconstriction in toxemia. Neurology 1987; 37: 1555–57.Google Scholar
Lewis, KL, Hinshaw, DB, Will, AD et al. CT and angiographic correlation of severe neurological disease in toxemia of pregnancy. Neuroradiology 1988; 30: 59–64.Google Scholar
Trommer, BL, Homer, D, Mikhael, MA. Cerebral vasospasm and eclampsia. Stroke 1988; 19: 326–29.CrossRefGoogle ScholarPubMed
Altura, BT, Altura, BM. The role of magnesium in etiology of strokes and cerebrovasospasm. Magnesium 1982; 1: 277–91.Google Scholar
White, RP, Cunningham, MP, Robertson, JT. Effects of the calcium antagonist nimodipine on contractile responses of isolated canine basilar arteries induced by serotonin, prostaglandin F2, thrombin, and whole blood. Neurosurgery 1982; 10: 344–48.CrossRefGoogle ScholarPubMed
Allen, GS, Ahn, HS, Preziosi, TH et al. Cerebral arterial spasm - a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 1983; 308: 619–24.CrossRefGoogle ScholarPubMed
Nowak, L, Bregestovski, P, Ascher, P, Herbert, A, Prochiantz, A. Magnesium gates glutamate-activated channels in mouse central neurons. Nature 1984; 307: 463–65.Google Scholar
Mayer, ML, Westbrook, GL, Guthrie, PB. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurons. Nature 1984; 309: 1224–25.Google Scholar
Dingledine, R, Hynes, MA, King, GL. Involvement of N-methyl-D-aspartate receptors in epileptiform bursting in the rat hippocampal slice. J Physiol 1986; 380: 175–89.CrossRefGoogle ScholarPubMed
Sadeh, M. Action of magnesium sulfate in the treatment of preeclampsia-eclampsia. Stroke 1989; 20: 1273–75.CrossRefGoogle ScholarPubMed